# Safety and Efficacy of Bimatoprost Solution in Increasing Overall Eyelash Prominence

> **NCT00693420** · PHASE3 · COMPLETED · sponsor: **Allergan** · enrollment: 278 (actual)

## Conditions studied

- Eyelashes

## Interventions

- **DRUG:** Bimatoprost 0.03% sterile solution
- **DRUG:** vehicle sterile solution

## Key facts

- **NCT ID:** NCT00693420
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-04
- **Primary completion:** 2007-10
- **Final completion:** 2007-12
- **Target enrollment:** 278 (ACTUAL)
- **Last updated:** 2013-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00693420

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00693420, "Safety and Efficacy of Bimatoprost Solution in Increasing Overall Eyelash Prominence". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT00693420. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
